Welcome
to a new era
FARMAK, a.s. has been renamed to CZECH-GEN, a.s. We are a private chemical and pharmaceutical company focused on the research, development, and production of active pharmaceutical ingredients, chemical products, and specialties.
Company Profile
CZECH-GEN is a leading Central European manufacturer in the chemical and pharmaceutical industry. The company's key competencies include research, process development, and GMP manufacturing of generic active pharmaceutical ingredients, advanced chemical specialties, and CDMO services from process development to commercial production.
90
Export production
80
Countries worldwide
500
Specialists
4
Group Divisions
Certification
CEP
EU GMP
US FDA
ASMF
US DMF
ISO 2020
European Union
USA
Japan
India
China
Latin America
Product and service offering
Traditional Czech manufacturer
with in-house development
01
Generic APIs
GMP manufacturing of active pharmaceutical ingredients for regulated markets including the USA, EU, and Japan.
02
CDMO services
Contract development and manufacturing, from process development and scale-up to commercial production.
03
Chemical Specialties
Advanced chemical specialties and custom synthesis for discerning B2B partners across industries.
Ready to get started?
Are you looking for a reliable API manufacturer or CDMO partner?
Contact us for active pharmaceutical ingredients, CDMO services, or chemical specialties.
Genesis and Continuity
CZECH-GEN
The common denominator of all entities within the group is a focus on quality, innovation, and raising standards in human healthcare.
MedicProgress
Custom development and contract manufacturing of cosmetics, dietary supplements, medical devices, veterinary medicines, and disinfectants.
FARMAK rEality
Residential development and property management.
CZECH-GEn Gastro
Gastronomic services and related operations of the group.
Ing. Jiří Žák
Founder · Chairman of the Supervisory Board CZECH-GEN GROUP
The foundations of the company were laid by Ing. Jiří Žák, who took over the management of the then-company Farmakon in 1990. After privatization and transformation into the joint-stock company FARMAK in 1992, the company underwent significant restructuring and modernization.
Continuous development and investments in technology have propelled the company among internationally recognized B2B partners, capable of meeting the most demanding global regulatory standards, including the US market.
1952
Establishment of the state enterprise Farmakon, n.p.
1992
Establishment of FARMAK, a.s. (joint-stock company)
1996
Expansion of the production program to include new substances
1998
First inspection by the American FDA
2026
Rebranding of FARMAK to the new brand CZECH-GEN
Portfolio
Product Portfolio for Regulated Markets
Overview of active pharmaceutical ingredients, chemical specialties, and related documentation for international pharmaceutical partners.
Alfuzosin Hydrochloride
Léčivá látka používaná při benigním zvětšení prostaty. Komerční API s dostupnou regulatorní dokumentací a definovanými dodacími parametry.
CAS RN:
81403-68-1
Therapeutic area:
Benign prostatic hyperplasia
API category:
Non-sterile small-molecule API
Production capacity:
15 000 kg/year
Standard lead time:
6 weeks
Research & Development
Innovation
is the foundation
of our success
Strong scientific and research background, in-house process development, and flexible manufacturing capabilities have positioned us among internationally recognized B2B partners.
Process Development & Scale-up
Reliable transition from laboratory to commercial scale.
Analytical Development
Validation and stability studies, quality control.
Regulatory Support
CEP, ASMF, DMF, and complete documentation for your registration.
Long history of successful inspections in the world's most regulated markets, including the USA.
Quality & Regulatory
US FDA
Long history of successful FDA inspections for the US market.
EU GMP
Manufacturing in compliance with EU Good Manufacturing Practice.
EU GMP
Manufacturing in compliance with EU Good Manufacturing Practice.
US / J-DMF
Long track record of successful FDA inspections for the US market.
CEP / ASMF
Certificates and documentation for European registrations.
Establish a business partnership
Are you looking for a partner
for development
and manufacturing?
Contact us for inquiries regarding active pharmaceutical ingredients, CDMO services, or chemical specialties.